Skip to main content
IC
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
2.480
0.00 (0.00%)
May 14, 2025, 12:53 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Therapeutics
194.62M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-33.46%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
194.62M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.46%
Log In
Log In
Log In
Log In
Upgrade